ICMR in process to procure 2 more mobile BSL-3 laboratories to bolster India's outbreak response
New Delhi: The Indian Council of Medical Research (
ICMR
) has initiated the process of procuring two more Mobile BSL-3 (MBSL-3) laboratories to step up
outbreak response capabilities
and bolster public health delivery, especially in remote and inaccessible areas.
Called
RAMBAAN
, there are currently two such laboratories - each stationed at ICMR's two institutes, the National Institute of Virology in Pune and the RMRC in Gorakhpur, UP.
RAMBAAN is the first of its kind Rapid Action Mobile BSL-3 laboratory and is fully indigenous. It is field-deployable and designed to meet enhanced diagnostic demands during outbreaks of known and unknown high-risk pathogens.
An initiative of ICMR, it was developed in partnership with Klenzaids Contamination Controls Private Limited, Mumbai, under the patronage of Pradhan Mantri-Ayushman Bharat Health Infrastructure Mission, Ministry of Health and Family Welfare, the apex research institute said.
The MBSL-3 was successfully deployed and operationalised for the first time during the Nipah virus (NiV) outbreak in Kozhikode, Kerala, in September 2023 and again in Malappuram district of the state in July 2024, it said.
This "laboratory on wheels" is built on a heavy-duty Bharat Benz vehicle chassis, compliant with BS-VI norms, designed to operate at extreme temperatures and altitudes and bears a maximum load capacity 17,000 kgs.
It is classified as a Type-IV Rapid Response Mobile Laboratory (RRML) as per WHO GOARN RRML laboratory network classification.
The laboratory is designed to maintain a negative air pressure environment and is equipped with an advanced heating, ventilation, and air conditioning (HVAC) system with HEPA filters.
It also features a double-door autoclave and a biological liquid effluent decontamination (BLED) and hydrogen peroxide (H2O2) fogger system for biological waste management.
The
MBSL-3 laboratory
's work area is divided into four zones -- zone-1 (driver and outer change room), zone-2 (shower and inner change room), zone-3 (main laboratory), and zone-4 (material staging and decontamination area).
Key installations within these zones include biological safety cabinets (Class II A2), an intelligent programmable logic controller system, a dynamic pass box, and an entry-exit shower system with biometric control.
The laboratory's power supply can be from a direct electric supply or a diesel generator, with an uninterrupted power supply (UPS) and petrol generators for backup. Communication within the laboratory is facilitated by walkie-talkies and real-time surveillance through CCTVs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
New study warns of rising cancer burden in Kerala
T'puram: A recent study presented at the Kerala Cancer Conclave 2025 reveals alarming cancer trends in the state, with Kerala reporting an average 88,460 cases annually—43,110 among males and 45,350 among females. The national average stands at 1.56 million cases, making Kerala's contribution significant at nearly 5.7% of India's total cancer burden. By 2030, projections indicate a further rise to 43,930 cases in men and 45,813 in women. The report presented by Prof Prashant Mathur, Director, ICMR-National Center for Disease Informatics and Research, Bengaluru, points to stark gender-based disparities in cancer prevalence. Among men, lung cancer leads at 14%, followed by oral cavity (10%), colorectal (10%), prostate (9%), and liver cancers (8%). For women, breast cancer dominates at 34%, with thyroid (11%), colorectal (9%), uterine (6%), and ovarian cancers (4%) following. Among males, the most common cancers were lung (14%), oral cavity (10%), colorectum (10%), prostate (9%), and Jliver (8%). In females, breast cancer accounted for a striking 34%, followed by thyroid (11%), colorectum (9%), corpus uteri (6%), and ovary (4%). Dr Mathur highlighted the rising prevalence of lung, prostate, and liver cancers in men, and breast and thyroid cancers in women. Liver cancer, in particular, continues to show a rapid increase across both genders over the past two decades. In terms of crude mortality rates in Kerala in 2024, lung cancer led among men at 28.9%, followed by liver (18.9%), prostate (11.2%), stomach (8.3%), and mouth (8.3%). For women, breast cancer had the highest crude mortality rate at 37.5%, followed by lung (8.3%), ovary (6.6%), thyroid (6.1%), and cervix uteri (5.2%). Lung cancer mortality among men in the state is 28.9%, while the national average is only 7.8%. For breast cancer in women, Kerala's mortality rate is 37.5%, far above the national average of 14.9%.
Time of India
2 hours ago
- Time of India
HP govt to hike stipend of dentists pursuing MD: CM
Shimla: Himachal chief minister Sukhvinder Singh Sukhu said on Friday that the state govt has hiked stipends, increasing the allowance for MD doctors from Rs 60,000 to Rs 1 lakh. "Similarly, stipends of super-speciality doctors and dental doctors pursuing MD will also be hiked," Sukhu said. Sukhu was presiding over the inter-college event 'Eruption-2025' at HP Government Dental College, Shimla, on Friday. Emphasising the importance of improving healthcare, he stated, "A patient's illness worsens without proper treatment, so ensuring timely and accurate care is essential." The state govt is set to invest Rs 1,100 crore in upgrading medical colleges, he added. Equipment similar to that in AIIMS is being brought to the state medical colleges, and within three months, PET Scan and 3-Tesla MRI machines will be installed in the medical colleges of the state. Major transformations in healthcare will be visible within a year, emphasised Sukhu. Highlighting the need for financial prudence, the chief minister stated that while the previous BJP govt misused the state's resources, the current govt is committed to ensuring development by saving every penny.
The Hindu
6 hours ago
- The Hindu
Kerala's cancer incidence has gone much above the national average, oncologists and public health experts say
As cancer incidence spirals in Kerala, oncologists and public health experts have called for targetted interventions to improve the awareness of risk factors for cancer and to encourage early diagnosis of the disease. Kerala's cancer incidence has gone much above the national average, with the State reporting an incidence of 243/lakh population in men and 219/lakh population in women, against the national average of 105/lakh for men and men and 103/lakh for women Kerala's cancer landscape was discussed in detail at the Kerala Cancer Conclave, which began here on Saturday. Cancers of the lung (14%) oral cavity (10%), colorectal (10%), prostate (9%) and liver (8%) are the leading cancers in men in Kerala. In women, breast cancer incidence has gone up 300 fold in Kerala in the last 25 years and today it accounts for 34 % of all cancers in women. Thyroid (11%), colorectal (9%) and uterine cancer (6%) have also been going up in women, while cervical cancer no longer figures among the first five cancers in women . Metastatic cancers Reeling off statistics, Prashant Mathur, the Director of ICMR-National Centre for Disease Informatics and Research, Bengaluru, pointed out that a huge number of locally advanced metastatic cancers were being reported in Kerala than anywhere else in the country and that early diagnosis of cancer was extremely important for bringing down the stage at diagnosis and thus, the cancer burden. He pointed out that Kerala did very well when it came to five-year survival rates, which spoke a lot about the quality of cancer care. The high proportion of the elderly in Kerala – 16.5% of the population in 2021 and which is projected to hit 22.8% in 2036, according to UNFPA's India's Ageing Report 2023 – could be the primary factor driving the cancer incidence in Kerala. In Pathanamthitta, one of the districts with the highest proportion of elderly, the cancer incidence was 300/lakh population. Specialised geriatric oncology services and a primary cancer prevention programme, integrated to the primary healthcare delivery, would be an intervention that Kerala would have to invest in, to check the rising burden of cancer, Aleyamma Mathew, cancer epidemiologist, said. Dr. Mathew said that when 90% of the breast cancers in the State were curable in early stages, two-thirds of cases were being reported to hospitals at stages 3 and 4. Even the educated in Kerala seemed to report very late to hospitals, making for a poor prognosis. Dr. Mathew pointed out that over the years, the drop-out rate in cancer treatment was going up in Kerala, with many patients refusing to turn up for follow-up treatment after the initial surgery. Renowned public health expert and epidemiologist, V. Ramankutty, sought to put Kerala's high cancer incidence in perspective, when he pointed out that Kerala's cancer incidence was still much lower than that of the West. Detection bias and Kerala's data gathering expertise could be the reasons for the State emerging with one of the highest cancer incidences in the country, he pointed out. Actual risk factors Dr. Ramankutty pointed out that the actual risk factors for cancer – lack of dietary fibre, poor consumption of vegetables, alcohol and lack of exercise – were not being adequately projected by authorities as risk factors for cancer and people continued to remain ignorant. If quests after cancer cure in alternative medicine and unscientific treatment methods were resulting in late diagnosis of cancer, catastrophic treatment expenses, inadequate insurance cover and loss of livelihood were the reasons why people were dropping out of cancer treatment, Dr. Ramankutty said. Unless the government addressed these issues and took steps to integrate comprehensive cancer care with primary care, Kerala's current cancer landscape was unlikely to change. Speaker A.N. Shamseer inaugurated the conclave, which is organised by the Association of Medical and Paediatric Oncologists of Kerala. The event has brought together over 200 oncology and public health experts. Those who participated in the discussions on Saturday included S.H. Advani, renowned oncologist to have pioneered bone marrow transplant in the country; C.S. Pramesh, director, Tata Memorial Hospital, Mumbai; B. Satheesan, director, Malabar Cancer Centre; M.R. Rajagopal, founder-director, Pallium India, among many others.
